Applications are evaluated based on four criteria:
- Scientific merit
- Innovation
- Clinical and medical impact
- Quality of research environment
![](/documents/3996983/3997187/ico_scientific_merit.png/821c7e93-ce01-f86f-dd71-4dc745686606?t=1649175852930)
Scientific merit
- The validity of the rationale / proposed methodology
- The validity of the expected outcomes
- The validity of the proposed timelines
- The feasibility of completing the proposed work within 18 months
![](/documents/3996983/3997187/ico_innovation.png/8d387962-4191-5c78-001d-9c1c74a4e863?t=1649175852219)
Innovation
- Innovation in design, methodology and objectives
![](/documents/3996983/3997187/ico_clinical.png/b01879df-dcdb-e853-b062-bf5df0587225?t=1649175853114)
Clinical / medical impact
- Contribution of the Research Project results to increase diagnosis and for clinical and scientific understanding
- Improve disease management or develop novel concepts on immune thrombocytopenia (ITP)
- Relevance of the project to the clinical practice for ITP
- Increase knowledge of SYK inhibition in ITP or other diseases.
![](/documents/3996983/3997187/ico_research.png/e9215502-68eb-e723-3e62-2eea9dfb803b?t=1649175853239)
QUALITY OF RESEARCH ENVIRONMENT
- Team clinical/scientific expertise and experience
- Qualification of the participants
- Expertise in the academic/clinical research environment